PRECISION BIOSCIENCES INC — Director's Dealing 2019

Mar 27, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-03-27

Reporting Person: THOMSON DAVID S. (Chief Development Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$1.18	2027-06-29	Common Stock (234226)		Direct
Employee Stock Option (Right to Buy)	$11.98	2028-09-27	Common Stock (187381)		Direct

Footnotes

F1: The option vests as to 25% of the underlying shares on May 31, 2018 and vests in equal installments at the end of each successive three-month period over the following 36 months.

F2: The option vests as to 34% of the underlying shares on September 28, 2018 and vests in equal installments at the end of each successive three-month period from September 28, 2019 through September 28, 2021.